This brand name is authorized in Cyprus, Estonia, France, Japan, Mexico, Netherlands, Spain, Tunisia, Turkey.
The drug MODIODAL contains one active pharmaceutical ingredient (API):
1
|
UNII
R3UK8X3U3D - MODAFINIL
|
|
Modafinil promotes wakefulness in a variety of species, including man. The precise mechanism(s) through which modafinil promotes wakefulness is unknown. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| N06BA07 | Modafinil | N Nervous system → N06 Psychoanaleptics → N06B Psychostimulants, agents used for ADHD and nootropics → N06BA Centrally acting sympathomimetics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| EE | Ravimiamet | 1627679, 1661903 |
| ES | Centro de información online de medicamentos de la AEMPS | 61540 |
| FR | Base de données publique des médicaments | 66805883, 68680058 |
| JP | 医薬品医療機器総合機構 | 1179047F1022 |
| MX | Comisión Federal para la Protección contra Riesgos Sanitarios | 522M2001 |
| NL | Z-Index G-Standaard, PRK | 110167 |
| TN | Direction de la Pharmacie et du Médicament | 5763041H |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8699638015207 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.